A Screening Success Story
Lung cancer remains a leading cause of cancer death, largely because it is typically diagnosed at advanced stages when symptoms finally appear, by which point treatment options and survival are significantly more limited. Low-dose CT screening for high-risk individuals represents one of the clearer screening success stories in oncology, with major trials demonstrating meaningful reduction in lung cancer mortality among those who qualify for and undergo regular screening.
Who Qualifies for Screening
Current guidelines generally recommend low-dose CT screening for adults within a specific age range who have a substantial smoking history, whether currently smoking or having quit within a defined recent period, reflecting the populations in whom the screening trials demonstrated clear mortality benefit. This targeted approach, rather than universal screening, reflects the trade-off between benefit and the harms of false positives and unnecessary procedures in lower-risk individuals.
Why Targeted Screening Makes Sense
Unlike screening tests applied broadly across a population, lung cancer screening is deliberately restricted to those at genuinely elevated risk, since the same screening applied to low-risk individuals would generate more false positives and incidental findings relative to actual cancers detected, tilting the risk-benefit calculation unfavorably. For those who do qualify, however, the evidence for mortality benefit is compelling, making awareness of eligibility criteria valuable for at-risk individuals and their clinicians. Facilities can source diagnostic equipment from our catalog.
